IP50-26: Oncologic Outcomes of BCG Versus Observation in Patients with Intermediate-Risk NMIBC
Sunday, May 17, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract
Speakers
SD
Simone D'Annunzio
Registered attendees
Scott Flanders
VP of Medical AffairsImmunityBio, Inc.